Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study

scientific article published in November 2001

Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S002210100839
P698PubMed publication ID11685410

P2093author name stringG Bernardi
M G Marciani
P Giacomini
M Pierantozzi
P Stanzione
M G Palmieri
P433issue1
P921main subjectParkinson's diseaseQ11085
apomorphineQ269111
P304page(s)52-62
P577publication date2001-11-01
P1433published inExperimental Brain ResearchQ13358841
P1476titleEffect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study
P478volume141

Reverse relations

cites work (P2860)
Q36774917An investigation of semantic similarity judgments about action and non-action verbs in Parkinson's disease: implications for the Embodied Cognition Framework
Q90344992Cerebellar Contribution to Motor and Non-motor Functions in Parkinson's Disease: A Meta-Analysis of fMRI Findings
Q58050082Chapter 26 Diseases and treatments: Parkinson's disease
Q48444556Combination of rTMS and treadmill training modulates corticomotor inhibition and improves walking in Parkinson disease: a randomized trial
Q38080951Cortical excitability and neurology: insights into the pathophysiology
Q44237429Cortico-motor excitability of the lower limb motor representation: a comparative study in Parkinson's disease and healthy controls
Q37385099Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease
Q35024422Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease
Q43860548Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study.
Q33785659Effects of More-Affected vs. Less-Affected Motor Cortex tDCS in Parkinson's Disease
Q44087190Excitability changes in human peripheral nerve axons in a paradigm mimicking paired-pulse transcranial magnetic stimulation
Q35938568Functional reorganization of sensorimotor cortex in early Parkinson disease.
Q48275827Increased intracortical inhibition in hyperglycemic hemichorea-hemiballism.
Q37035605Increased motor cortical facilitation and decreased inhibition in Parkinson disease
Q46414655Inhibitory and excitatory intracortical circuits across the human sleep-wake cycle using paired-pulse transcranial magnetic stimulation
Q43280990Interactions between short latency afferent inhibition and long interval intracortical inhibition
Q44489205Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: a paired TMS study.
Q48489411Modulation of human motor cortex excitability by single doses of amantadine
Q43115293Motor cortex excitability correlates with novelty seeking in social anxiety: a transcranial magnetic stimulation investigation.
Q45242475Motor cortex stimulation for Parkinson's disease and dystonia: lessons from transcranial magnetic stimulation? A review of the literature
Q60733379Motor intracortical inhibition in PD: L-DOPA modulation of high-frequency rTMS effects
Q38739709Motor learning in animal models of Parkinson's disease: Aberrant synaptic plasticity in the motor cortex
Q36203600Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials
Q34261531Paired-pulse inhibition in the auditory cortex in Parkinson's disease and its dependence on clinical characteristics of the patients.
Q47868277Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance
Q35754187Role of hyperactive cerebellum and motor cortex in Parkinson's disease
Q26865819Safety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature.
Q34383595Slow (1 Hz) repetitive transcranial magnetic stimulation (rTMS) induces a sustained change in cortical excitability in patients with Parkinson's disease.
Q37300186Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease
Q30479500The effects of Parkinson's disease and age on syncopated finger movements
Q97570189Use of transcranial magnetic stimulation in the treatment of selected movement disorders
Q84431366WITHDRAWN: Mechanisms Underlying Inhibitory and Facilitatory Transcranial Magnetic Stimulation Abnormalities in a Large Sample of Patients with Parkinson's Disease

Search more.